That's interesting... only skimmed it but just pondering again... they seem to have a clearer picture when looking at patients with rheumatic disease rather than patients with IBD, I wonder if the IBD cases are perhaps confounded by perhaps IBD patients on anti-TNF biologics tending to have more severe cases of IBD relative to IBD patients not taking them?